Sanofi Long-Term Concentrated

Location: Paris, France

CIK: 0001121404 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 7, 2026

Total Value: $336M (100.0% shares, 0.0% debt)

Holdings (9)

MGTX MeiraGTx Holdings plc 31.4%

Value $106M Shares 12,197,737 Est. Cost $5.86 Unrealized +29.9%

INBX Inhibrx Biosciences, Inc. 23.2%

Value $77.85M Shares 1,157,926 Est. Cost $15.23 Unrealized +410.3%

NVAX Novavax 16.7%

Value $56.01M Shares 6,880,481 Est. Cost $9.64 Unrealized -10.4%

ANAB AnaptysBio 9.0%

Value $30.38M Shares 821,917 Est. Cost $24.22 Unrealized +103.8%

AGMB Agomab Therapeutics NV 8.7%

Value $29.19M Shares 2,783,096 Est. Cost $10.49 Unrealized —

MPLT MapLight Therapeutics Inc. 5.5%

Value $18.54M Shares 912,041 Est. Cost $16.75 Unrealized +5.2%

IMRX Immuneering Corp 4.2%

Value $14.27M Shares 2,708,559 Est. Cost $5.19 Unrealized -1.3%

ELDN Eledon 0.7%

Value $2.51M Shares 814,980 Est. Cost $3.94 Unrealized -47.1%

QTTB Q32 Bio Inc. 0.5%

Value $1.567M Shares 244,083 Est. Cost $31.58 Unrealized -87.5%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
MGTX	MeiraGTx Holdings plc	12,197,737	$106M	31.4%	$5.86	+29.9%	COM	G59665102
INBX	Inhibrx Biosciences, Inc.	1,157,926	$77.85M	23.2%	$15.23	+410.3%	COM	45720N103
NVAX	Novavax	6,880,481	$56.01M	16.7%	$9.64	-10.4%	COM NEW	670002401
ANAB	AnaptysBio	821,917	$30.38M	9.0%	$24.22	+103.8%	COM	032724106
AGMB	Agomab Therapeutics NV	2,783,096	$29.19M	8.7%	$10.49	—	SPONSORED ADS	00860C102
MPLT	MapLight Therapeutics Inc.	912,041	$18.54M	5.5%	$16.75	+5.2%	COM	56565P103
IMRX	Immuneering Corp	2,708,559	$14.27M	4.2%	$5.19	-1.3%	CLASS A COM	45254E107
ELDN	Eledon	814,980	$2.51M	0.7%	$3.94	-47.1%	COM	28617K101
QTTB	Q32 Bio Inc.	244,083	$1.567M	0.5%	$31.58	-87.5%	COM	746964105